Ferdinando De Vita

University of Campania "Luigi Vanvitelli"

Papers

2

Total Citations

9

H-Index

2

About

Ferdinando De Vita is a leading oncologist whose research centers on the surgical and multidisciplinary management of pancreatic neuroendocrine tumors (pNETs) and gastrointestinal cancers. His major contributions lie in refining treatment algorithms for these rare, complex malignancies, particularly through comparative analyses of surgical approaches such as enucleation versus distal pancreatectomy. His most-cited work, "Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?" (2024), has accumulated 9 citations, underscoring its timely impact on clinical decision-making. De Vita’s research emphasizes the critical need for personalized, multidisciplinary planning to address the unique challenges of functional and non-functional pNETs, which are often diagnosed at advanced stages. By synthesizing evidence on surgical outcomes and hormonal syndromes, he has helped clarify optimal strategies for improving patient survival and quality of life. His work is particularly valued by surgeons and oncologists navigating the nuances of rare tumor management. De Vita’s ongoing contributions continue to shape best practices, making him a respected voice in the field of pancreatic oncology and a key resource for clinicians and researchers dedicated to advancing care for patients with neuroendocrine tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?
5 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of Campania "Luigi Vanvitelli"

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago